secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2022-04-26T23:59:59+00:00
Accession:  0001157523-22-000474
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q1 net sales $273M (-11% YoY), EPS $1.15 (-21% YoY); cuts FY2022 guidance
-------------------------------------------------------------------------------

- Net sales $272.9M, down 11% YoY; diluted EPS $1.15, down 21% from $1.45.
- Asia Pacific net sales $218.4M (-13% YoY); Greater China down 10%; Southeast Asia Pacific down 24%.
- Active customers 552,000, down 11% YoY; Americas & Europe active customers down 10%.
- Revised FY2022 outlook: net sales $1.1-1.2B (was $1.125-1.225B), EPS $5.00-5.70 (was $5.25-6.00).
- Company repurchased $25M in shares in Q1; $83M remaining under authorization; cites China COVID lockdowns as headwind.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752322000474/0001157523-22-000474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752322000474/a52698273.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-000474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer